These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6704329)

  • 1. Fibrinogen Adelaide: a familial hypodysfibrinogenaemia associated with abnormal alpha chains.
    Exner T; Barber S; Sage RE; Kronenberg H
    Br J Haematol; 1984 Jan; 56(1):95-106. PubMed ID: 6704329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hereditary dysfibrinogenemia: fibrinogen Awaji.
    Matsuo T; Okuno S; Mukaida T; Ueshima S; Okada K; Matsuo O
    Haemostasis; 1987; 17(1-2):89-97. PubMed ID: 3596361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Episodes of increased fibronectin level observed in a patient suffering from recurrent thrombosis related to congenital hypodysfibrinogenaemia (fibrinogen Malmoe).
    Soria J; Soria C; Hedner U; Nilsson IM; Bergqvist D; Samama M
    Br J Haematol; 1985 Dec; 61(4):727-38. PubMed ID: 4084461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution.
    Steinmann C; Bögli C; Jungo M; Lämmle B; Heinemann G; Wermuth B; Redaelli R; Baudo F; Furlan M
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):463-71. PubMed ID: 7841300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen Troyes--fibrinogen Metz. Two new cases of congenital dysfibrinogenemia.
    Soria J; Soria C; Samama M; Poirot E; Kling C
    Thromb Diath Haemorrh; 1972 Jul; 27(3):619-33. PubMed ID: 4662617
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinogen Oviedo I. A new Spanish dysfibrinogenaemia.
    Fernández FJ; Rodríguez Pinto C; Páramo J; Cuesta B; Collado M; Rocha E
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):571-5. PubMed ID: 2133236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Lima. A new dysfibrinogenaemia with a high-molecular-weight alpha-chain and effective polymerization.
    Arocha-Piñango CL; Rodriguez S; Nagy H; Perez Requejo JL
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):561-5. PubMed ID: 2133234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An abnormal inherited fibrinogen (fibrinogen Genova) with delayed fibrin aggregation.
    Hassan HJ; Orlando M; Tonini GP; Casalbore P; Sarti A; Boeri E; Giacchino R; Tentori L; Mori PG
    Scand J Haematol; 1982 Oct; 29(4):287-94. PubMed ID: 7178834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genotype and function analyses of four inherited dysfibrinogenemia pedigree caused by Arg16 amino acid substitution in fibrinogen Aα chain].
    Jiang LL; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):475-9. PubMed ID: 22967385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional study of abnormal fibrinogen caused by Arg275His mutation in fibrinogen γ chain].
    Zhou JY; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):190-4. PubMed ID: 23683413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of reptilase and thrombin-induced changes in fibrinogen subunits by isoelectric focussing.
    Exner T; Rickard KA; Kronenberg H
    Thromb Res; 1983 Aug; 31(3):489-97. PubMed ID: 20218004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'.
    Vorjohann S; Fish RJ; Biron-Andréani C; Nagaswami C; Weisel JW; Boulot P; Reyftmann L; de Moerloose P; Neerman-Arbez M
    Thromb Haemost; 2010 Nov; 104(5):990-7. PubMed ID: 20806111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
    Bögli C; Cofrancesco E; Cortellaro M; Della Volpe A; Hofer A; Furlan M; Zanussi C
    Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism.
    Martinez J; Holburn RR; Shapiro SS; Erslev AJ
    J Clin Invest; 1974 Feb; 53(2):600-11. PubMed ID: 11344575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
    Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
    Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
    Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M
    Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
    Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
    Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
    Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S
    Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
    Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G
    Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.